2026 Annual Seminar Schedule at a Glance

*Seminar Schedule Subject to Change.
Friday Schedule
Saturday Schedule
Sunday Schedule

Friday, April 24, 2026

12:00pm – 6:00pm
Registration Open

12:30pm – 2:00pm
Presidents Lunch

1:00pm
Opening Remarks

1:05pm – 2:05pm (General Session)
Oregon Pharmacy Formulary Update
Presented by Courtney Sellers and Gary Runyon

2:10pm – 3:10pm (General Session)
Preceptor Development
Presented by Maddie Frye and Ryan Gibbard

3:10pm – 3:30pm
Break

3:30pm – 4:30pm (Non-CE Session)
IRC Presentation
Presented by TBD

4:40pm – 5:40pm
Clinical Pearls

The Use of Metformin in Antipsychotic Induced Weight Gain
Presented by Trixy Angelie Pilando Ibis, PharmD
Transformation to Standard of Care regulation of Pharmacy Practice
Presented by Mike Millard, BPharm
Medications that interfere with Continuous Glucose Monitors (CGMs)
Presented by Margaux Groff, PGY1 Pharmacy Resident
Be Informed: Updates to the 2026 AHA/ASA Guidelines for Early Management of Acute Ischemic Stroke
Presented by Rosalind Wong, PharmD
Optimizing Medication Therapy by Recognizing Prescribing Cascades
Presented by Trang Fulltran
The Role of GLP-1 Agonists in SUD
Presented by Annie Saefong
Impact of a Pharmacist-managed Concierge Service on 340B Utilization, Apothecary Prescriptions and Hospital Admission Rates: a Quality Improvement Pilot Study
Presented by Zack McCall
Amoxicillin Dosing
Presented by Young Yoon Ham


5:45pm – 7:00pm
Welcome Reception with Exhibitors 

Saturday, April 25, 2026

6:00am – 7:00am
Fun Run

7:00am – 5:30pm
Registration Open

7:30am – 8:00am
Continental Breakfast with Exhibits

8:00am – 8:05am
Opening Remarks

8:10am – 9:10am (General Session / Opening Session)
Oregon Indian Country: Tribal Sovereignty’s Impact on Health Care
Presented by Claymore Kills First

9:15am – 10:15am (General Session)
The Whole Kidney and Caboodle: Incorporating Guideline-Based Recommendations to Identify and Manage Chronic Kidney Disease and Reduce Cardiovascular Risks
Presented by Lavinia Salama, PharmD, BCACP, BCGP, BC-ADM, CDCES - Clinical Assistant Professor at Long Island University, Arnold & Marie Schwartz College of Pharmacy and Health Sciences and Ambulatory Care Clinical Pharmacist at One Brooklyn Health, Pierre Toussaint Health Center Brooklyn, New York

Most patients with chronic kidney disease (CKD) are unaware they have it. Guidelines have established well-known risk factors for CKD to help identify and screen patients, but many patients remain unscreened and untreated, leading to kidney disease progression, cardiovascular disease, morbidity, and mortality. As the most accessible healthcare professionals, pharmacists are uniquely positioned to identify and screen patients at risk for CKD. Pharmacists can apply guideline recommendations to provide holistic care and improve outcomes and reduce cardiovascular risks for patients with CKD. This educational activity will discuss the cardiovascular risks of CKD and approaches to identifying and screening patients at risk of CKD. This activity will also provide strategies to implement guideline-recommended care of CKD and provide real-world examples of best practices in multidisciplinary care and patient education to equip and inspire pharmacists to bridge gaps across the cardiovascular-kidney-metabolic spectrum.

This presentation is provided by ASHP. Supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

10:15am – 11:15am
Break with Exhibitors

10:15am – 11:15am
Poster Session

11:30am – 12:30pm
Lunch Buffet with Legislative Update and Office Induction 

12:30pm – 2:00pm (General Session)
Oregon Emergency Preparedness
Presented by Amy Cervan and Amber Taylor

2:00pm – 2:30pm
Break – Refreshments, Section Networking, Fundraising

2:30pm – 3:30pm (Track A)
PrEPared in Primary Care: Putting PrEP into Practice
Presented by Jess Potter

2:30pm – 3:30pm (Track B)
Rewriting Disease: Gene Therapy and Gene Editing in Today’s Pharmacy
Presented by Sigrid Roberts and Nicola Carter 

3:35pm – 4:35pm (Track A)
GDMT Without Gaps: Building and Maintaining Optimal Therapy Across the Patient Journey
Presented b y Alyssa Rabon

3:35pm – 4:35pm (Track B)
FDA-Approved Anti-Amyloid Therapy for Alzheimer's Disease: New Evidence and Practice Updates
Presented by Marketa Marvanova

6:00pm – 8:00pm
Awards Celebration
Doors & Auction Open: 6:00pm
Dinner Service Begins: 6:30pm

Sunday, April 26, 2026

7:30am – 8:30am
Breakfast and Registration

8:00am – 8:05am
Opening Remarks

8:05am – 9:05am (General Session)
BOP Law Update
Presented by Gary Runyon

9:10am – 10:10am (General Session)
Hypertension 2025 Guideline Update
Presented by Abby Frye

10:15am – 10:30am
Break

10:30am – 11:30am (General Session)
Deprescribing Therapy
Presented by Katherine Marks

11:30am – 11:40am (General Session)
Closing Remarks

11:45am
Seminar Ends

*Schedule, topics, presenters and CE Type schedule to change.